Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,849-1,860 of 1,909
Drug study icon
CompletedEUCTR 2005-000211-99

Acutely Manic Patients Insufficiently Responding After 2 Weeks Continued Quetiapine Monotherapy: Continued Quetiapine Versus Sodium Valproate Add-on.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Denmark
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrugA study involving a medication or substance.
Countries
Denmark
Sponsor
AstraZeneca A/S
Condition
Bipolarity
Drug study icon
TerminatedEUCTR 2006-002006-60

Functional neuroanatomy and regional metabolism in depressed patients with quetiapin: An fMRI-guided MRS study on a 7 Tesla scanner

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrug
Countries
Germany
Sponsor
Otto-von-Guericke University
Condition
Bipolarity
Drug study icon
Recruitment unclearEUCTR 2011-003190-29

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication according to the the ABCB1 Gene

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, Bipolarity, ...Drug
Countries
Germany
Sponsor
HolsboerMaschmeyer NeuroChemie (HMNC) GmbH
Condition
Schizophrenia, Bipolarity, ...
Device study icon
Not recruitingISRCTN17308399

The gameChange study: automated virtual reality therapy to help people with psychosis feel more confident in everyday situations

This study is looking at whether a digital support tool can help people with Clinical diagnosis of schizophrenia spectrum psychosis or an affective diagnosis with psychotic symptoms, self-reported difficulties going outside the home primarily due to anxiety, Mental and Behavioural Disorders, or Schizophrenia, schizotypal and delusional disorders Bipolarity, current episode manic with psychotic symptoms Bipolarity, current episode severe depression with psychotic symptoms Severe depressive episode with psychotic symptoms Recurrent depression, current episode severe with psychotic symptoms. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, Depression, ...Other
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia, Depression, ...
Drug study icon
Not recruitingEUCTR 2021-006773-38

TSPO ligands in the treatment of depression: proof-of-concept of efficacy and underlying mechanisms of action

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Regensburg
Why is this study shown?

This study includes Bipolarity among several conditions.

Depression, BipolarityDrug
Countries
Germany
Sponsor
Medizinische Einrichtungen des Berzirks Oberpfalz
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT00357006

A Definitive Estrogen Patch Study (ADEPT)

This summary needs review. Please check the official study record and contact the research team for details.

In Melbourne
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrugFrom 18 Years to 50 Years
Countries
Australia
Sponsor
The Alfred
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00363376

Zonisamide to Prevent Olanzapine-Associated Weight Gain

This study is completed in the United States. It focuses on Bipolarity.

In Mason
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrugOver 18 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Bipolarity
Device study icon
CompletedNCT00534781

Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Baltimore
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States
Sponsor
ArthroCare Corporation
Condition
Bipolarity
Drug study icon
CompletedNCT04701827

Affective Disorders: Eliminate WArning Signs And REstore Functioning: AWARE

This summary needs review. Please check the official study record and contact the research team for details.

In Hillerød
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrugFrom 18 Years to 65 Years
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.